scholarly journals Microwave ablation of autonomously functioning thyroid nodules: a comparative study with radioactive iodine therapy on the functional treatment success

2020 ◽  
Author(s):  
Mehmet Sercan Ertürk ◽  
Bulent Cekic ◽  
Mehmet Celik ◽  
Isil Demiray Uguz
Keyword(s):  
Comparative Study ◽  
Microwave Ablation ◽  
Thyroid Nodules ◽  
Radioactive Iodine ◽  
Treatment Success ◽  
Functional Treatment ◽  
Radioactive Iodine Therapy ◽  
Autonomously Functioning Thyroid Nodules

scholarly journals Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves’ Disease

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Se Hee Park ◽  
Sena Hwang ◽  
Seunghee Han ◽  
Dong Yeob Shin ◽  
Eun Jig Lee
Keyword(s):  
Body Mass Index ◽  
Treatment Outcome ◽  
Radioactive Iodine ◽  
Treatment Success ◽  
Graves Disease ◽  
Clinical Parameters ◽  
Radioactive Iodine Therapy ◽  
Effective Treatment Option ◽  
Factors Associated ◽  
Immunoglobulin Levels

Radioactive iodine (RAI) therapy is an effective treatment option for Graves’ disease. However, predicting treatment failures after RAI therapy remains controversial. The objective of this study was to investigate the factors associated with the success rate of RAI therapy for treatment of Graves’ hyperthyroidism. Thyroid functional outcome, pre-RAI ultrasonographic features, and clinical parameters were evaluated retrospectively in 98 patients followed up for at least 12 months after RAI (mean RAI dose was 11.7 ± 1.8 mCi). Hypothyroidism was achieved in 59 patients (60.2%), and euthyroidism in 16 patients (16.3%), while 23 patients (23.5%) remained hyperthyroid. Age, sex, body mass index, pre-RAI thyroid function, or thyroid-stimulating immunoglobulin levels were not associated with treatment outcome. Length of thyroid isthmus (p=0.028) and 2- to 24-hour iodine uptake ratios (p=0.002) were significantly associated with treatment failure, which was defined as a persistent hyperthyroid status after RAI therapy. Patients with a longer isthmus had a higher risk of remaining hyperthyroid, with a threshold for isthmus length of 5.2 mm, with a sensitivity of 69.6% and specificity of 70.3% for treatment success. Measuring the length of the thyroid isthmus can be a simple and useful way to predict RAI treatment outcome.

scholarly journals Manifestation of Marine Lenhart Syndrome after failed Radioactive Iodine therapy

2021 ◽  
Author(s):  
Francis Essien ◽  
Callie Cheatham ◽  
Blake Elkins ◽  
Joshua Tate
Keyword(s):  
Current Literature ◽  
Thyroid Nodules ◽  
Radioactive Iodine ◽  
Tsh Receptor ◽  
Radioactive Iodine Therapy ◽  
Receptor Antibodies ◽  
Tsh Receptor Antibodies ◽  
Radioactive Iodine Ablation

Marine Lenhart Syndrome (MLS) is caused by a coexistence of active thyroid nodules and Graves’ disease1. Here, we present a case of hyperthyroidism characterized by the presence of stimulating TSH receptor antibodies, unsuccessful radioactive iodine ablation, ultimately requiring Methimazole followed by thyroidectomy. We review the current literature.

Abstract #1116 Radioactive Iodine Therapy for Graves Disease: What Predicts Failure?

2018 ◽  
Vol 24 ◽  
pp. 281-282
Author(s):  
Kalyani Regeti ◽  
Rajinikanth Yatavelli ◽  
Harsha Karanchi ◽  
Binod Pokhrel
Keyword(s):  
Radioactive Iodine ◽  
Graves Disease ◽  
Radioactive Iodine Therapy

Hyperparathyroidism subsequent to radioactive iodine therapy for Graves' disease

Head & Neck ◽  
2021 ◽  
Author(s):  
Richard H. Law ◽  
Daniel L. Quan ◽  
Andrew J. Stefan ◽  
Edward L. Peterson ◽  
Michael C. Singer
Keyword(s):  
Radioactive Iodine ◽  
Graves Disease ◽  
Radioactive Iodine Therapy
Sign in / Sign up

Export Citation Format

Share Document